WALTHAM, Mass. – September 24, 2013 – X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, today announced it has achieved several milestones leading to the licensing of three drug discovery programs by AstraZeneca, in the context of a collaboration the […]

WALTHAM, MA, USA – (July 1, 2010) – X-Chem, Inc. today announced the signing of a multi-year collaborative agreement with Roche to apply X-Chem’s proprietary platform to the rapid discovery of drug candidates against several of Roche’s high-value therapeutic targets.